Evidence map›Paper›PMID 34276702›Full record

ArticleFrontiers in immunology2021

Dysregulation of the Immune Environment in the Airways During HIV Infection.

Rubina Bunjun, Andreia P Soares, Narjis Thawer, Tracey L Müller, Agano Kiravu, Zekarias Ginbot, Björn Corleis, Brandon D Murugan, Douglas S Kwon, Florian von Groote-Bidlingmaier and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Rubina BunjunInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Andreia P SoaresInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Narjis ThawerInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Tracey L MüllerInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Agano KiravuInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Zekarias GinbotInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Björn CorleisRagon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.
Brandon D MuruganInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Douglas S KwonRagon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.
Florian von Groote-BidlingmaierDivision of Pulmonology, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Catherine RiouInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Robert J WilkinsonInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Gerhard WalzlDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Wendy A BurgersInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZARagon Institute of MGH, MIT and Harvard · USSouth African Medical Research Council · ZAStellenbosch University · ZAWellcome Centre for Infectious Diseases Research in Africa · ZA

Funding

Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
Diversity of CD4+ Th subsets in TB immunity - Impact of HIV infectionR21AI115977 · NIAID · UNIVERSITY OF CAPE TOWN · PI RIOU, CATHERINE, WHERRY, E. JOHN · 2015 to 2016
$351k
Cancer Research UK FC0010218Medical Research Council FC0010218NIAID NIH HHS R21 AI115977NIAID NIH HHS U01 AI115940Wellcome Trust 104803Wellcome Trust 203135Wellcome Trust FC0010218
6 · The paper itself

Abstract

HIV-1 increases susceptibility to pulmonary infection and disease, suggesting pathogenesis in the lung. However, the lung immune environment during HIV infection remains poorly characterized. This study examined T cell activation and the cytokine milieu in paired bronchoalveolar lavage (BAL) and blood from 36 HIV-uninfected and 32 HIV-infected participants. Concentrations of 27 cytokines were measured by Luminex, and T cells were phenotyped by flow cytometry. Blood and BAL had distinct cytokine profiles (p=0.001). In plasma, concentrations of inflammatory cytokines like IFN-γ (p=0.004) and TNF-α (p=0.004) were elevated during HIV infection, as expected. Conversely, BAL cytokine concentrations were similar in HIV-infected and uninfected individuals, despite high BAL viral loads (VL; median 48,000 copies/ml epithelial lining fluid). HIV-infected individuals had greater numbers of T cells in BAL compared to uninfected individuals (p=0.007); and BAL VL positively associated with CD4+ and CD8+ T cell numbers (p=0.006 and p=0.0002, respectively) and CXCL10 concentrations (p=0.02). BAL T cells were highly activated in HIV-infected individuals, with nearly 2-3 fold greater frequencies of CD4+CD38+ (1.8-fold; p=0.007), CD4+CD38+HLA-DR+ (1.9-fold; p=0.0006), CD8+CD38+ (2.8-fold; p=0.0006), CD8+HLA-DR+ (2-fold; p=0.022) and CD8+CD38+HLA-DR+ (3.6-fold; p<0.0001) cells compared to HIV-uninfected individuals. Overall, this study demonstrates a clear disruption of the pulmonary immune environment during HIV infection, with readily detectable virus and activated T lymphocytes, which may be driven to accumulate by local chemokines.

Indexed as

AdultBronchoalveolar Lavage FluidCytokinesFemaleHIV InfectionsHumansLungLymphocyte ActivationMaleT-LymphocytesViral LoadCytokinesactivationcytokinesHIVinflammationlungT cells

Identifiers

PMID34276702
PMCPMC8278481
OpenAlexW3176159510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.